Company / Interest Expense per Share
Niagen Bioscience, Inc. Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2023
5-year range
-$0.00 / $0.00
FY2019-FY2023
Trend
+105.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share returned to growth in FY2023 after 3 years of decline, reaching $0.00.
Based on SEC 10-K filings.
0.00 in FY2023 with a 5-year CAGR of -57.2%.
Improved from $0.00 to $0.00 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -85.9%
- 5-Year CAGR
- -57.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, interest expense per share increased 105.0% year-over-year.
- Peak interest expense per share was recorded in FY2019.
- Lowest interest expense per share in the period was in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.00 | +105.0% |
| FY2022 | -$0.00 | -170.4% |
| FY2021 | $0.00 | -91.9% |
| FY2020 | $0.01 | -99.9% |
| FY2019 | $15.38 | +549555.5% |
| FY2018 | $0.00 | -31.4% |
| FY2017 | $0.00 | -56.0% |
| FY2016 | $0.01 | +71.9% |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026